Back to Results

EA2165 A Randomized Phase III Study of Nivolumab after Combined Modality Therapy (CMT) in High Risk Anal Cancer

Study category: Cancer

Is this Study for You?

Let's Get Started!




III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.

Type of Study



Greeley Campus
Harmony Campus
Lone Tree Medical Center
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Pikes Peak Regional Hospital
Poudre Valley Hospital
University of Colorado Hospital

Principal Investigator
Alexis Leal

Alexis Leal

Study ID

Protocol Number: 18-1216 NCT03233711

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers